FDA grants marketing approval to GlaxoSmithKline’s diabetes drug based on Novozymes’ Veltis technology

(Source: News-Medical.net) “This is yet another important market approval for a drug based on Novozymes’ Veltistechnology”, says Dermot Pearson, Marketing Director, Novozymes …